Evidence map›Paper›PMID 37621572›Full record

ArticlePhysical therapy research2023

Characteristics and Related Factors of One-year Transition in Exercise Tolerance Following an Emergency Declaration due to the Coronavirus Disease 2019 Pandemic in Patients on Phase III Cardiac Rehabilitation.

Tatsuro Kitayama, Taishi Tsuji, Kenta Mikami, Naoto Usui, Ryo Emori, Yasuyuki Maruyama, Tadanori Harada

Open access · diamondAbstract read
In one paragraph

Article in Physical therapy research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 90% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Tatsuro KitayamaDepartment of Rehabilitation, Itabashi Heart Clinic, Japan.
Taishi TsujiFaculty of Health and Sport Sciences, University of Tsukuba, Japan.
Kenta MikamiDepartment of Rehabilitation, Iwatsuki Minami Hospital, Japan.
Naoto UsuiDepartment of Rehabilitation, Kisen Hospital, Japan.
Ryo EmoriDepartment of Rehabilitation, Sonoda Third Hospital, Japan.
Yasuyuki MaruyamaDepartment of Cardiology, Iwatsuki Minami Hospital, Japan.
Tadanori HaradaDepartment of Cardiology, Itabashi Heart Clinic, Japan.
Sapporo Minami Hospital · JPMisasa Onsen Hospital · JPSonoda Women's University · JPUniversity of Tsukuba · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThis study aimed to understand the long-term transition of exercise tolerance in patients on phase III cardiac rehabilitation (CR) and clarify the characteristics of patients with a high risk of declined exercise tolerance during the first emergency declaration.

methodsPatients who participated in phase III outpatient CR before the first emergency declaration and those who performed cardiopulmonary exercise testing were at ≥2-time points: before and at 3 or 12 months post-emergency declaration. Exercise tolerance transition at 3-time points was analyzed, and whether different social background factors affected the peak oxygen uptake (V̇O

resultsA total of 101 (median age 74.0 years, 69% men), and both peak V̇O

conclusionThe emergency declaration declined the exercise tolerance in patients on phase III CR but improved to pre- declaration levels over time, but more likely declined in patients with multiple comorbidities during pre-declaration and those with low-gait speeds were less likely to improve their declined exercise tolerance.

Indexed as

ComorbidityCOVID-19Gait speedPeak V̇O2

Identifiers

PMID37621572
PMCPMC10445121
OpenAlexW4367162966

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.